Dissertation

Iyo Novel Eclectic Nzira yeCancer Therapy ine Liquid Knife & Immuno Therapy: UMIPIC, inogona Kupfuura Kuvhiya kwakawanda, Chemotherapy uye Radiation Therapy kune ese Matanho eSolid Tumor.

Mushonga Wakasanganiswa neH2 O2 Jekiseni Intratumoral kushandura Extracellular Matrix kuita Autologous Coagulum seDhipatimendi rezvinodhaka.

Tariro Itsva yeCancer Therapy neLiquid Knife & Immuno Therapy: UMIPIC

Acute Tumor Inflammation ine CD4/8+ uye CD11+ Yakakwidziridzwa Yenguva Yekupona Kwenguva muMatanho ePamusoro eese Solid tumors neUltra Minimum Incision Personalized Intratumoral Chemoimmunotehrapy.

Acute Inflammation ine Special Expression yeCD11 & CD4 Inoburitsa Abscopal Effect neIntramoral Injection Chemotherapy Mushonga une Hapten muMhuka Model.

Nguva Itsva ye lmmuno Surgery iri Kuuya: A Novel Eclectic Approach yeCancer Kurapa neLiquid Knife & lmmuno Therapy.

Acute Tumor Inflammation neCD4/8+ uye CD11+ Rebesa The Survival Effect Induced by Intratumral Injection Optimum Combination of Chemotherapy Drugs with Hydralazine as Hapten in Animal Model.

Awaken Immune Cells naHapten Enhanced Intratumoral Chemotherapy nePenicillin Prolong Pancreatic Cancer Survival.

Kubudirira kunanga mune situ ye oncogenic nuclear antigen nehapten induced bundu rinobatanidza autoantibodies (iTAA)

Shanduko dzeImmune Dzinokonzereswa neIntratumoral Hapten Plus Chemotherapy Mishonga yeEndometrialCancer.

Cancer Immunotherapy Kugadzirira uye Immune Cells Activation kuburikidza neHapten-Enhanced Chemotherapy muPrimary Lung Cancer.

Chemical immune conization ye precancerous cervical maronda anomutsa masero edziviriro uye anodzoreredza yakajairika HPV isina kunaka uye kupararira kusingawanzo.

Mhedzisiro yesodium stibogluconate mukuunganidza uye kumutsa masero edziviriro mu pleural fluid yepancreatic cancer: kugadzirira immunotherapy.

Shandisa scRNA-Seq Profile kutsanangura Immunologic Response mushure meIntra-tumor Hapen Enhanced Chemotherapy paNyaya yeIntracranial Anaplastic Hemangiopericytoma Liver Metastasis: Nyaya Yenyaya.

Hapten-Mediated Chemical Immune Therapy neDrug Administration muCervical Cancer pasina Hysterectomy: Kumutsa Maseru Edziviriro eImmunotherapy.

Kuwanikwa kweBiomarker muhepatocellular carcinoma (HCC) yekurapa kwakasarudzika uye kuwedzera kufungidzira.

Dissertation

Ndapota tisiyire meseji